These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7984787)

  • 1. Current and investigational approaches for reversing established osteoporosis.
    Kimmel DB; Slovik DM; Lane NE
    Rheum Dis Clin North Am; 1994 Aug; 20(3):735-58. PubMed ID: 7984787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
    Schacht E
    Z Rheumatol; 1994; 53(5):274-98. PubMed ID: 7810237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mechanisms and targets in the treatment of bone fragility.
    Martin TJ; Seeman E
    Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American College of Sports Medicine position stand. Osteoporosis and exercise.
    Med Sci Sports Exerc; 1995 Apr; 27(4):i-vii. PubMed ID: 7791573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone as an anabolic therapy for women and men.
    Bilezikian JP; Rubin MR; Finkelstein JS
    J Endocrinol Invest; 2005; 28(8 Suppl):41-9. PubMed ID: 16329201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different routes of administration and the effect of hormone replacement therapy on osteoporosis.
    Christiansen C
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):152S-156S. PubMed ID: 7958010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
    Dimai HP
    Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The parathyroid hormones: bone-forming agents for treatment of osteoporosis.
    Whitfield JF; Morley P; Willick GE
    Medscape Womens Health; 2000; 5(5):E5. PubMed ID: 11113778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis: preventive strategies.
    Kulak CA; Bilezikian JP
    Int J Fertil Womens Med; 1998; 43(2):56-64. PubMed ID: 9609204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.